Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,772,118
+$3,217,046 QoQ
Shares Held
22,938
+95.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,227
of 4,153 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Signal Advisors Wealth, LLC holds $29,778,924 across 9 Drug Manufacturers - General names. ABBV ranks #3 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,191 | $13,422,822 | |
| 2 | JNJ |
Johnson & Johnson
|
23,993 | $6,093,502 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
22,938 | $5,772,118 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,779 | $2,156,101 | |
| 5 | AMGN |
Amgen Inc
|
2,041 | $739,086 | |
| 6 | AZN |
Astrazeneca PLC
|
2,706 | $513,111 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,813 | $450,185 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,752 | $347,687 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,772,118 | 22,938 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,555,072 | 11,748 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,332,096 | 5,830 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $696,009 | 3,006 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $890,047 | 4,795 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $363,098 | 1,733 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $291,783 | 1,642 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $278,446 | 1,410 | Shares | Sole | 2024-10-15 | |
| 2024-03-31 | $332,332 | 1,825 | Shares | Sole | 2024-04-10 | |
| No filing history on record for this holder in this stock. | ||||||